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Since the original observation that mice maintained on  a  diet of cheese or 
given daily injections of nutrose  (sodium caseinate) are susceptible to amyloid 
disease (1), the casein model has been used to study the pathogenesis of this 
disorder. Nevertheless, despite the reproducibility of amyloid induction in mice, 
guinea pigs, rabbits, and even chickens after multiple casein injections (2), the 
chemical composition of the amyloid substance in these species is not known nor 
is it certain whether the changes in their tissues represent a primary or second- 
ary form of anayloidosis. 
Amyloid fibrils of human and animal origin appear identical when examined 
by staining techniques and by high resolution microscopy. Amino acid sequence 
studies have shown the human primary amyloid fibrils to be homologous with 
fragments of immunoglobulin light chains (3), while secondary fibrils are com- 
posed of a unique 76 residue sequence of nonimmunoglobulin origin, A  protein 
(4, 5). This communication provides the first chemical analysis of casein-induced 
amyloid fibrils in guinea pigs and demonstrates its similarity to the major non- 
immunoglobulin component of human secondary amyloid fibril preparations. 
Materials and Methods 
Induction of Amyloid.--Amyloidosis was induced in guinea pigs by multiple subcutaneous 
injections of 10% sodium caseinate.  After 6 mo the animals were sacrificed and their spleens 
removed for further studies. 
Isolation of Amyloid Fibrils.--Amyloid fibrils were isolated from eight spleens, AC73-35 by 
repeated homogenization in saline. The residue was then homogenized in water and the amyloid 
fibrils recovered by lyophilization  of the water suspension and the top layer (6). 
Chromatography.--The isolated amyloid fibrils were  added to 4  M  guanidine, pH  7.5, 
allowed to stand at 4°C for 24 h, and centrifuged.  Approximately one-half of the fibrils re- 
mained in the residue. The supernatant solution of amyloid fibrils was chromatographed on a 
Sepharose 6B column (90 x 2.5 cm, Pharmacia Fine Chemicals, Inc., Piscataway, N. J.)  using 
4 M guanidine, pH 7.5 (Fig. 1). The resulting peaks 1, 2, and 3 were dialyzed against distilled 
water and recovered by lyophilization. The major retarded peak, peak 4, was recovered  by 
desalting on a P2 column (Bio-Rad Laboratories, Richmond,  Calif.) eluted with 0.1 N  acetic 
acid. 
Amino acid Analysis.--Amino acid analyses were performed on a JEOL-SAH analyser after 
hydrolysis in 6 N  HCI at 110  ° C for 20 h.  Each phenylthiohydantoin (PTH)  residue after 
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sequence degradation was converted to its free amino acid by hydrolysis in 57% hydriotic acid 
(Fisher Scientific Co., Pittsburgh, Pa.) at 125°C for 20 h and the identity confirmed by amino 
acid analysis (7). 
Sequence Studies.--4.3  mg of peak 4 were dissolved in 0.6 ml of 10% acetic acid and se- 
quenced according to the method of Edman and Begg  (8)  on a  Beckman Sequencer Model 
890C  (Beckman Instruments, Inc.,  Fullerton,  Calif.).  The  PTH  amino acid  residues were 
identified on a Beckman 65 gas chromatograph (9). 
RESULTS 
At the end of the 5-mo injection period the guinea pig spleens were markedly 
infiltrated with amyloid. Gel chromatography of the isolated fibrils which dis- 
solved in 4 M guanidine (Fig. 1) revealed a void volume peak and four retarded 
peaks.  The major retarded peak, peak 4,  represented  25 %  of the  recovered 
material. Peak 5 could not be separated from the guanidine on a P2 desalting 
column. 
Amino acid analyses of the starting fibrils, the residue after guanidine extrac- 
tion, and each of the first three peaks showed a marked similarity in composition 
(Table I). However, differences were found in the composition of peak 4 which 
had  a  greater  arginine,  aspartic  acid,  and  alanine  content  and  decreased 
amounts of threonine, proline, cystine, valine, and leucine. 
Sequence studies on the guinea pig peak 4 confirmed its homology with the A 
protein  of secondary amyloid with  the  exception of a  5-residue  N-terminal 
peptide,  His-Ala-Lys-Gly-Glu, preceding the usually reported human  N-ter- 
minal peptide Arg-Ser-  (Table II) (4, 5). There was a substitution of isoleucine 
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FIO. 1. Gel chromatography of guinea pig amyloid fibrils through Sepharose 6B (2.5  cm x 
90 cm) eluted with 4 M guanidine HC1, pH 7.5, and collected in 3-ml fractions. 
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TABLE  I 
Amino Acid A nalysis of A myloid Fibrils from Guinea Pigs (Residues/100 Residues) 
873 
Amyloid  Residue after 
fibrils  guanidine 
extraction 
Sepharose  6B chromatography 
Peak 1  Peak 2  Peak 3  Peak 4 
Lysine  6.3  5.2  5.1  5.3  5.9  5.0 
Histidine  2.0  2.3  2.5  2.4  2.2  2.0 
Arginine  5.9  5.4  5.2  5.5  6.3  8.3 
Hydroxyproline  trace  1.0  0  0  0  0 
Asparfic acid  8.2  8.4  8.4  8.6  8.2  10.6 
Threonine  4.6  4.7  5.2  5.1  4.8  2.7 
Serine  5.7  5.4  7.0  6.4  5.6  5.4 
Glutamic acid  11.4  11.2  11.7  12.4  12.7  11.9 
Proline  5.4  5.8  6.6  5.5  5.2  3.5 
Glycine  10.6  10.8  11.1  11.1  7.7  10.8 
Alanine  10.9  9.2  7.5  8.3  9.9  15.6 
Cystine  1.2  1.4  1.9  1.4  2.7  0.4 
Valine  5.7  6.3  6.0  6.1  6.2  3.6 
Methionine  2.3  2.1  1.8  1.9  2.1  3.2 
Isoleucine  4.3  4.6  4.2  4.0  4.4  2.4 
Leucine  8.2  8.8  7.9  8.2  8.8  5.5 
Tyrosine  3.3  3.1  3.3  3.1  3.4  4.0 
Phenylalanine  4.0  4.4  4.7  4.5  3.8  5.0 
TABLE II 
Comparison of Experimental Amyloid in Guinea Pigs with Human A protein, 
Monkey A protein, and Human P component 
Guinea Pig A protein 
Human A protein (5) 
Monkey Aprotein (4) 
Human P component (ll) 
Guinea Pig A 
Human A 
Monkey A 
Human P 
Guinea Pig A 
Human A 
Monkey A 
Human P 
1  2  3  4  5 
His-Ala-Lys-Gly-G  lu-Arg-Ser-Ile-Phe-Ser- 
Arg-Ser-Phe-Phe-Ser 
Arg-Ser-Trp-Phe-Ser- 
His-Ala-Asp-Leu-  (  )-Thr-Lys-Val-Phe-Val- 
6  7  8  9  10  11  12  13  14  15 
Phe-Leu-Lys-Glu-Ser/Ala-Gly-( )-Gly-Pro-(  )- 
Phe-Leu-Gly-Glu-Ala-Phe-Asp-Gly-Ala  -Arg- 
Phe-Leu-Gly-Glu-Ala-Tyr-Asp-Gly-Ala-Arg- 
Phe-(  )-(  )-Ser-Glu-Val-Val-(  -Ser-Val- 
16  17  18  19  20 
Asp-Met-Leu-  (  )-Ser/Ala- 
Asp-Met-Trp-Arg-Ala- 
Asp-Met-Trp-Arg-Ala 
Val-Ser-Ile- 
for  phenylalanine  at  position 3,  lysine  for  glycine  at  position  8,  glycine  for 
phenylalanine at position 11, proline for alanine at position 14, and leucine for 
tryptophan at position 18. 
Antiserum prepared in rabbits to the guanidine-denatured guinea pig amyloid 
fibrils gave  a  single  precipitin line  when  tested  by  double  diffusion  in  agar 
against the guanidine-denatured fibrils or the isolated peak 4 material (Fig. 2). 
The  antiserum  also detected a  cross-reacting substance in amyloidotic guinea 874  SKINNER  ET.  AL.  BRIEF  DEFINITIVE  REPORT 
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FIO. 2(a).  Double-diffusion  analysis of antiserum to denatured amyloid fibrils of guinea 
pig origin (anti-GP A) vs. guinea pig P-component (GP P), amyMdotic serum (GP S), and 
isolated A protein  (GP A) showing complete identity  between guinea pig A protein and a 
component in guinea pig serum. No reaction is noted with human A protein (H A), serum (H S) 
or P component (H P). (b) Double-diffusion  analysis of antiserum to A protein of human origin 
vs. the same antigens as in 2 a. No reactivity with guinea pig proteins is seen. 
pig  serum  which  showed  complete  identify  to  the  isolated  peak  4  protein. 
The antiserum to  guinea pig A  protein gave no  reaction with human A  pro- 
tein  or amyloidotic human serum. Conversely, antiserum to human A protein 
did not react with guinea pig A protein nor with amyloidotic guinea pig serum. 
The presence of weak precipitin lines against antiserum to guanidine-denatured 
guinea pig  fibrils  identified  trace  amounts  of  A  protein  in  the  chromato- 
graphed peaks 1,  2,  and 3. 
DISCUSSION 
In this study, sequence analysis of experimentally induced guinea pig amyloid 
fibrils has  revealed the  secondary  (A protein,  nonimmunoglobulin)  nature  of 
these fibrils when compared to  the known sequences of the human A  protein 
(Table II). Amyloid associated with chronic granulomatous disease in monkeys 
has also been shown to contain the unique A protein sequence (Table II) (4, 10). 
Deletions in the first one, two, or three amino acids, Arg-Ser-Phe, of A protein 
have been noted in the human A protein sequence. The current study demon- 
strates an additional  N-terminal peptide  (His-Ala-Lys-Gly-Glu) in the guinea 
pig. While the significance of this finding is not known, it has been suggested 
that A  protein might be derived by proteolysis of a  larger protein because of SKINNER  ET  AL.  BRIEF  DEFINITIVE  REPORT  875 
individual  N-terminal  variations.  Also,  the  demonstration  of  a  guinea  pig 
serum factor immunologically identical with the A protein is consistent with a 
circulating precursor of the amyloid fibrils. 
When the N-terminal sequence of A protein from human and monkey amyloid 
are compared, substitutions are noted in two positions, 3 and  11. As might be 
expected phylogenetically, more substitutions,  a total of five, are found when 
the guinea pig and human A protein are compared. In terms of the nucleotide 
interchange for the codon of the amino acids two of these, positions 3 and 14, 
represent first base changes and three of these, positions 8, 11, and 18, represent 
second base changes. Equal amounts of serine and alanine at positions 10 and 20 
is thought to be individual variations found in this study since the sample con- 
sisted of pooled guinea pig spleens. 
We have previously noted the sequence beginning His-Ala in the amyloid- 
associated protein, human P component (Table II) (11), but this sequence to 23 
residues is not homologous with A protein. P component is a minor constituent 
of amyloid  tissues,  and  is  antigenically identical  to  a  plasma  alpha  globulin 
found in both normal and amyloidotic subjects (12). Neither human nor guinea 
pig P  components react with either human or guinea pig antisera to A  protein 
(Fig.  2).  In  conclusion,  the present  study not  only provides a  definitive  N- 
terminal  sequence  analysis  of  experimental  anayloid  fibrils,  but  chemically 
verifies their relationship to secondary amyloid. 
SUMMARY 
Amyloidosis was produced experimentally in guinea pigs by multiple casein 
injections. Amyloid fibrils were isolated and fractionated and a protein obtained 
that had an amino acid composition comparable with A protein, a unique non- 
immunoglobulin  constituent  of  secondary  amyloid  deposits.  N-terminal  se- 
quence analysis demonstrated a sequence homologous with that of A proteins 
from human  and  monkey preparations  but  preceded by  a  5-residue peptide 
which had an N-terminal histidine.  A definite species specificity in A protein 
from human and guinea pig was identified on immunologic analysis. 
The  authors would  like  to  acknowledge  the  excellent  technical assistance of  Miss  Gail 
Stanton. 
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